Skip navigation

Canlyniadau chwilio am the

Yn dangos 391 i 405 o 1966 canlyniadau

Focus on ensuring high quality

Supporting information which expands on the delivery elements of Preceptorship Principle 2 - Quality & oversight of preceptorship

The standards of proficiency for speech and language therapists

The standards of proficiency that speech and language therapists must meet in order to join, and remain on, the HCPC Register. 

The costs of fitness to practise - a study of the Health and Care Professions Council

This study aims to generate descriptive statistics for different features of the HCPC’s Fitness to Practise processes and to address some specific questions regarding the factors which impact on costs.

Performance review requirements 2023-24 - what to expect

We emailed education providers due their performance review in 2023-24 in late June. Providers who will undergo the process this year (2023-24) will have been given specific requirements and a key contact to work with at the HCPC.

Diversity data: practitioner psychologists - July 2023

This factsheet provides key EDI information for practitioner psychologists and how the demographics of this group compare to the demographics of HCPC registrants overall

Diversity data: arts therapists - March 2023

This factsheet provides key EDI information for arts therapists and how the demographics of this group compare to the demographics of HCPC registrants overall

Diversity data: radiographers - March 2023

This factsheet provides key EDI information for radiographers and how the demographics of this group compare to the demographics of HCPC registrants overall

Performance review requirements 2023-24 - what to expect

We emailed education providers due their performance review in 2023-24 in late June. Providers who will undergo the process this year (2023-24) will have been given specific requirements and a key contact to work with at the HCPC.

Launch of consultation for the standards of conduct, performance and ethics

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

HCPC response to the HEE consultation on framework 15

 View our response to the Health Education England consultation on framework 15.

Top